Verona Pharma plc
Industry
- Pharmaceuticals
- Drug Delivery
- Pulmonary
- Vaccines
- Specialty Pharmaceuticals
- Drug Delivery
- Biotechnology
Other Names/Subsidiaries
- Isis Resources
- Rhinopharma
Latest on Verona Pharma plc
Financing of UK biotech companies nearly doubled in 2024 compared with the year before, with £3.5bn ($4.34bn) being raised to support new and existing companies. That represented a 94% increase in tot
A healthy total of 61 novel drugs were approved in the US in the course of 2024, but just a handful of these look certain to generate the multi-billion dollar sales that big pharma increasingly needs.
A healthy total of 61 novel drugs were approved in the US in the course of 2024, but just a handful of these look certain to generate the multi-billion dollar sales that big pharma increasingly needs.
The big respiratory players will be casting envious glances at the launch of Verona Pharma’s chronic obstructive pulmonary disorder (COPD) drug, Ohtuvayre, which is going from strength to strength. Th